European Respiratory Society Monograph, Vol. 27. 2004
ISBN: 978-1-84984-000-2
DOI: 10.1183/1025448x.erm2703
Pulmonary vascular pathology forms an important challenge in daily clinical practice; pulmonary embolism (PE) is the third leading cause of cardiovascular mortality in North America and is responsible for 5-10% of all in-hospital deaths. Furthermore, the diagnosis of PE remains one of the most difficult problems confronting clinicians. Timely diagnostic testing must be performed to enable the initiation of antithrombotic therapy for patients proven to have this condition while avoiding the risks of anticoagulation for patients without PE. The widespread adoption of right heart catherisation in the 1950s, for the study of heart and lung disease in humans, allows identification of patients suffering from pulmonary hypertension (PH). In case of exclusion of other causes of PH, this unexplained PH is designated as primary. The present monograph "Pulmonary Vascular Pathology: A Clinical Update" reviews the current knowledge in this field of pulmonary medicine. In particular, a better understanding of the actual pathogenesis of these pathologies offers perspectives of optimism in the future management of these patients.
Preface E.F.M. Wouters Eur Respir Mon; 2003: 27: a |  |
Introduction M. Demedts, M. Delcroix, R. Verhaeghe, G.M. Verleden Eur Respir Mon; 2003: 27: b |  |
Genetic and acquired risk factors of venous thromboembolism R. Verhaeghe, P. de Moerloose, J.C. Eikenboom, K. Peerlinck, A. Perrier, J. Vermylen, M.M. Samama, and the other participants of the working group “Management of pulmonary embolism” Eur Respir Mon; 2003: 27: 1–14 |  |
Diagnostic aspects of pulmonary embolism R. Verhaeghe, P. de Moerloose, I. Greer, M.V. Huisman, R. Hustinx, M. Monreal, L. Mortelmans, A. Perrier, M. Remy-Jardin, A. Torbicki, E.J.R. van Beek, and the other participants of the working group “Management of pulmonary embolism” Eur Respir Mon; 2003: 27: 15–24 |  |
Therapeutic aspects of pulmonary embolism R. Verhaeghe, G. Agnelli, C. Becattini, H. Decousus, G. Simonneau, E.J.R. van Beek, and the other participants of the working group “Management of pulmonary embolism” Eur Respir Mon; 2003: 27: 25–32 |  |
Pulmonary arterial hypertension: genetics, reversibility testing and follow-up M. Delcroix, N.W. Morrell, M. Abramowicz, O. Sitbon, A. Boonstra, N. Galie, E. Grünig, P. Hervé, R.C. Trembath, A.J. Peacock, M.M. Hoeper, and the other participants of the working group “Pulmonary arterial hypertension” Eur Respir Mon; 2003: 27: 33–56 |  |
Pulmonary arterial hypertension: current therapies M. Delcroix, W. Budts, P.A. Corris, W. Daenen, M. Gewillig, R. Naeije, H. Olschewski, J. Pepke-Zaba, W. Seeger, J-L. Vachiéry, D. Van Raemdonck, C.D. Vizza, and the other participants of the working group “Pulmonary arterial hypertension” Eur Respir Mon; 2003: 27: 57–83 |  |
Pulmonary hypertension: future therapies M. Delcroix, P. Dorfmüller, M.R. MacLean, J.A. Barbera, M.M. Hoeper, H. Ghofrani, S. Adnot, S. Eddahibi, S. Janssens, A.J. Peacock, J. Pepke-Zaba, D. Vizza, and the other participants of the working group “Pulmonary arterial hypertension” Eur Respir Mon; 2003: 27: 84–109 |  |
Imaging of pulmonary embolism: an overview E.J.R. van Beek, A.R. Moody, M. Oudkerk Eur Respir Mon; 2003: 27: 110–123 |  |
Spiral computed tomography angiography of pulmonary embolism M. Remy-Jardin, B. Ghaye, J. Remy Eur Respir Mon; 2003: 27: 124–143 |  |
Echocardiography: diagnostic and prognostic value in the assessment of pulmonary embolism A. Torbicki Eur Respir Mon; 2003: 27: 144–154 |  |
Prospects for the prevention and treatment of venous thromboembolism G. Agnelli, C. Becattini Eur Respir Mon; 2003: 27: 155–164 |  |
Evidence-based diagnostic algorithms for pulmonary embolism: why are they necessary? A. Perrier Eur Respir Mon; 2003: 27: 165–176 |  |
Pulmonary embolism and pregnancy I.A. Greer Eur Respir Mon; 2003: 27: 177–190 |  |
Pathophysiology of pulmonary arterial hypertension R. Naeije, P. Dorfmüller Eur Respir Mon; 2003: 27: 191–203 |  |
World Health Organization classification and risk factors for pulmonary arterial hypertension M. Humbert, O. Sitbon, G. Simonneau Eur Respir Mon; 2003: 27: 204–226 |  |
Prevention and early diagnosis of pulmonary hypertension A.J. Peacock Eur Respir Mon; 2003: 27: 227–242 |  |
Chronic thromboembolic pulmonary hypertension: update 2004 I.M. Lang, D. Bonderman, J. Jakowitsch, N. Skoro-Sajer, W. Klepetko, M. Kneussl Eur Respir Mon; 2003: 27: 243–252 |  |